FDA advisory committee considers Pfizer's COVID-19 vaccine for children ages 5 to 11

A Food and Drug Administration advisory committee is meeting Tuesday to consider endorsing Pfizer's COVID-19 vaccine for children ages 5 to 11. Dr. Mark Kline, chief physician at New Orleans Children's Hospital, spoke with CBSN's Tanya Rivero about what's next.

from Home - CBSNews.com https://ift.tt/3nvvZc9